Pharma Industry
Industry: Email Alert RSS FeedIvax Gets Drug OK
Chemical Market Reporter, March, 1997
IVAX CORPORATION, Miami, Fla., has been granted final marketing approval for etodolac and acyclovir by US Food & Drug Administration. Ivax says it has already begun offering 400 mg tablets of etodolac, the generic equivalent of Lodine (Wyeth-Ayerst), a non-steroidal anti-inflammatory. Ivax also intends to begin marketing acyclovir in 400 mg and 800 mg tablets when that drug's patent runs out April 22.
Acyclovir is the generic equivalent of Zovirax (Glaxo).
Premium Content Partnership |
HighBeam Research provides an in-depth online archive library of reference works.
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
